We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
NHS prostate cancer risk management programme (PCRMP) guidance on performing an ultrasound-guided prostate biopsy.
Guidance for healthcare professionals on using single-use medical devices.
These directions required NHS England to establish a division to be known as the Healthcare Safety Investigation Branch (HSIB) on 1 July 2022. These directions were revoked on 1 October 2023, and accordingly the HSIB no long…
Guidance on the cardiovascular safety of Cox-2 inhibitors and NSAIDs and further reading.
How to consider applications from NHS pensioners wishing to return to work for the NHS.
Terms of reference for the government's review of the safety of the health and care landscape.
Information for NHS patients and service users.
Guidance on the use and safety of bisphosphonates for bone-related conditions.
Provides clarification on some areas of the 'never events' policy framework, which aims to protect patients from avoidable harm.
Explains the connection between the Adult Social Care Framework, the NHS Outcomes Framework and the Public Health Outcomes Framework.
Sets out the terms of reference for the independent review of children's hearing services in England.
Explains how the national friends and family test results and data should be published.
Sets out legal responsibilities for the management of information in NHS organisations.
Tool to help NHS organisations and commissioners understand the productivity and cost elements associated with treating pressure ulcers.
Information for patients, public and healthcare professionals
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system.
Videos to help healthcare professionals understand, safeguard and care for women and girls affected by female genital mutilation (FGM).
How to use RamaXL, including system availability, running reports and how to subscribe.
Summarises incidence and mechanisms of NAI resistance in seasonal influenza viruses and availability of NAI susceptibility testing in UK.
Deficiencies in Omega’s pharmacovigilance system are not thought to affect the safety of the products that they market.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).